1
|
Wang L, Li J, Mu Q, Zhu L, Wang Y, Sheng Y, Zhao D, Yang G, Yu X, Wu X, Li Miao. Study on immune persistence of the CTN-1V strain rabies vaccine in humans. J Virus Erad 2024; 10:100365. [PMID: 38590730 PMCID: PMC10999804 DOI: 10.1016/j.jve.2024.100365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2023] [Accepted: 03/01/2024] [Indexed: 04/10/2024] Open
Abstract
This study is a single-arm, single-center phase IV clinical trial on a rabies vaccine that has been marketed in China. The Vero cells and CTN-1V strain are used in the rabies vaccine product. The purpose of this study was to investigate the safety, immunogenicity and immune persistence of this product. One hundred and forty-nine participants were enrolled to the study, all of whom were included in the safety analysis set (SS), among which 116 participants were included in the protocol analysis set (PPS), One hundred and fifteen participants were included in the 6-month immune persistence analysis set (IPS6) and 111 in the 12-month immune persistence analysis set IPS12. Results showed that: 1) In the SS analysis set, adverse reactions were mainly pyrexia and pain at the vaccination site, the severity of which were mostly grade 1, and concentrated in 0-3 days after vaccination. No grade 3 or above adverse events and serious adverse events (SAE) related to the experimental vaccine were observed. 2) In the PPS analysis set, the antibody positive conversion rate reached 100% at 14 days after full immunization of the pre-immunized negative population; The antibody geometric mean titer (GMT) (95% CI) was 14.82 (13.00, 16.90). 3) The positive rate of serum neutralizing antibody was 93.91 % and the GMT at 1.58 IU/ml at 6 months after full immunization. The positive rate of neutralizing antibody was 85.59 % and GMT at 1.30 IU/ml at 12 months after immunization. Our results show that the human rabies vaccine with the CTN-1V strain and Vero cells as matrix had good safety, immunogenicity and immune persistence in our study.
Collapse
Affiliation(s)
- Lidong Wang
- Changchun Zhuoyi Biological Co., Ltd, No.2 Yongxin Road, Changchun, 130000, China
| | - Jia Li
- National Institutes for Food and Drug Control, No. 29, Huatuo Road, Beijing, 100010, China
| | - Qiuyue Mu
- Guizhou Provincial Center for Disease Control and Prevention, No. 73 Bageyan Road, Guizhou, 550000, China
| | - Lei Zhu
- Changchun Zhuoyi Biological Co., Ltd, No.2 Yongxin Road, Changchun, 130000, China
| | - Yunpeng Wang
- National Institutes for Food and Drug Control, No. 29, Huatuo Road, Beijing, 100010, China
| | - Ying Sheng
- Changchun Zhuoyi Biological Co., Ltd, No.2 Yongxin Road, Changchun, 130000, China
| | - Danhua Zhao
- National Institutes for Food and Drug Control, No. 29, Huatuo Road, Beijing, 100010, China
| | - Guoling Yang
- Changchun Zhuoyi Biological Co., Ltd, No.2 Yongxin Road, Changchun, 130000, China
| | - Xiaoqing Yu
- Guizhou Provincial Center for Disease Control and Prevention, No. 73 Bageyan Road, Guizhou, 550000, China
| | - Xiaohong Wu
- National Institutes for Food and Drug Control, No. 29, Huatuo Road, Beijing, 100010, China
| | - Li Miao
- Changchun Zhuoyi Biological Co., Ltd, No.2 Yongxin Road, Changchun, 130000, China
| |
Collapse
|
2
|
Mu Q, Zhou B. [Progress of researches on molecular mechanisms underlying helminth infection-mediated type 1/2 host immune responses]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2023; 35:534-538. [PMID: 38148546 DOI: 10.16250/j.32.1374.2023101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 12/28/2023]
Abstract
Helminth infections are widespread worldwide, and pose a serious threat to human health and animal husbandry development. Understanding of helminth-host interactions is critical to effective control and ultimate eradication of helminthiasis. Following host infections, helminth infections firstly initiate innate immune responses and then mediate adaptive immune responses. Type 1 immune responses are predominant at early stage of helminth infections, which mainly play anti-infective actions, and type 2 immune responses are predominant at late stage of infections, which are associated with helminth immune evasion and aggravation of tissue damages. This review summarizes the progress of researches on type 1/2 immune responses-associated signaling pathways mediated by helminth infections in hosts.
Collapse
Affiliation(s)
- Q Mu
- Department of Parasitology, Zunyi Medical University, Zunyi, Guizhou 563000, China
| | - B Zhou
- Department of Parasitology, Zunyi Medical University, Zunyi, Guizhou 563000, China
| |
Collapse
|
3
|
Liu M, Zhao T, Mu Q, Zhang R, Liu C, Xu F, Liang L, Zhao L, Zhao S, Cai X, Wang M, Huang N, Feng T, Lei S, Yang G, Cui F. Immune-Boosting Effect of the COVID-19 Vaccine: Real-World Bidirectional Cohort Study. JMIR Public Health Surveill 2023; 9:e47272. [PMID: 37819703 PMCID: PMC10569382 DOI: 10.2196/47272] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2023] [Revised: 06/25/2023] [Accepted: 08/08/2023] [Indexed: 10/13/2023] Open
Abstract
BACKGROUND As the SARS-CoV-2 attenuates and antibodies from the COVID-19 vaccine decline, long-term attention should be paid to the durability of primary booster administration and the preventive effect of the second or multiple booster doses of the COVID-19 vaccine. OBJECTIVE This study aimed to explore the durability of primary booster administration and the preventive effect of second or multiple booster doses of the COVID-19 vaccine. METHODS We established a bidirectional cohort in Guizhou Province, China. Eligible participants who had received the primary booster dose were enrolled for blood sample collection and administration of the second booster dose. A retrospective cohort for the time of administration was constructed to evaluate antibody attenuation 6-12 months after the primary booster dose, while a prospective cohort on the vaccine effect of the second booster dose was constructed for 4 months after the second administration. RESULTS Between September 21, 2022, and January 30, 2023, a total of 327 participants were included in the final statistical analysis plan. The retrospective cohort revealed that approximately 6-12 months after receiving the primary booster, immunoglobulin G (IgG) slowly declined with time, while immunoglobulin A (IgA) remained almost constant. The prospective cohort showed that 28 days after receiving the second booster, the antibody levels were significantly improved. Higher levels of IgG and IgA were associated with better protection against COVID-19 infection for vaccine recipients. Regarding the protection of antibody levels against post-COVID-19 symptoms, the increase of the IgG had a protective effect on brain fog and sleep quality, while IgA had a protective effect on shortness of breath, brain fog, impaired coordination, and physical pain. CONCLUSIONS The IgG and IgA produced by the second booster dose of COVID-19 vaccines can protect against SARS-CoV-2 infection and may alleviate some post-COVID-19 symptoms. Further data and studies on secondary booster administration are required to confirm these conclusions.
Collapse
Affiliation(s)
- Ming Liu
- Guizhou Center for Disease Control and Prevention, Guiyang, China
| | - Tianshuo Zhao
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China
- Vaccine Research Center, School of Public Health, Peking University, Beijing, China
- Center for Infectious Diseases and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China
- Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China
| | - Qiuyue Mu
- Guizhou Center for Disease Control and Prevention, Guiyang, China
| | - Ruizhi Zhang
- Guizhou Center for Disease Control and Prevention, Guiyang, China
| | - Chunting Liu
- Guizhou Center for Disease Control and Prevention, Guiyang, China
| | - Fei Xu
- Guizhou Center for Disease Control and Prevention, Guiyang, China
| | - Luxiang Liang
- Guizhou Center for Disease Control and Prevention, Guiyang, China
| | - Linglu Zhao
- Guizhou Center for Disease Control and Prevention, Guiyang, China
| | - Suye Zhao
- Guizhou Center for Disease Control and Prevention, Guiyang, China
| | - Xianming Cai
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China
- Vaccine Research Center, School of Public Health, Peking University, Beijing, China
- Center for Infectious Diseases and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China
- Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China
| | - Mingting Wang
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China
- Vaccine Research Center, School of Public Health, Peking University, Beijing, China
- Center for Infectious Diseases and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China
- Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China
| | - Ninghua Huang
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China
- Vaccine Research Center, School of Public Health, Peking University, Beijing, China
- Center for Infectious Diseases and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China
- Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China
| | - Tian Feng
- Guizhou Center for Disease Control and Prevention, Guiyang, China
| | - Shiguang Lei
- Guizhou Center for Disease Control and Prevention, Guiyang, China
| | - Guanghong Yang
- Guizhou Center for Disease Control and Prevention, Guiyang, China
| | - Fuqiang Cui
- Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, China
- Vaccine Research Center, School of Public Health, Peking University, Beijing, China
- Center for Infectious Diseases and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China
- Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China
| |
Collapse
|
4
|
Wu S, Li X, Ma L, Li Y, Mu Q. Zoonotic orf virus infection during the mpox global outbreak. QJM 2023; 116:714-715. [PMID: 37137276 DOI: 10.1093/qjmed/hcad079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/01/2023] [Indexed: 05/05/2023] Open
Affiliation(s)
- S Wu
- Department of Dermatology, The First Hospital of Hohhot, Hohhot 010030, China
| | - X Li
- Department of Dermatology, The First Hospital of Hohhot, Hohhot 010030, China
- Department of Allergy, The First Hospital of Hohhot, Hohhot 010030, China
| | - L Ma
- Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China
| | - Y Li
- Department of Dermatology, The First Hospital of Hohhot, No. 150 Southern 2nd Ring Road, Yuquan District, Hohhot, Inner Mongolia 010030, China
- Department of Allergy, The First Hospital of Hohhot No. 150 Southern 2nd Ring Road, Yuquan District, Hohhot, Inner Mongolia 010030, China
| | - Q Mu
- Department of Dermatology, International Mongolian Hospital of Inner Mongolia, No. 83 University East Road, Saihan District, Hohhot, Inner Mongolia 010020, China
| |
Collapse
|
5
|
Chen Y, Xiao Y, Ye Y, Jiang F, He H, Luo L, Chen H, Shi L, Mu Q, Chen W, Guo X, Zhang M, Li J, Guan Q, Chen Z, Yang X. Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China. Front Immunol 2022; 13:1080408. [PMID: 36569946 PMCID: PMC9772018 DOI: 10.3389/fimmu.2022.1080408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Accepted: 11/28/2022] [Indexed: 12/12/2022] Open
Abstract
Background Few data exist on the immunogenicity and safety of an inactivated enterovirus 71 vaccine (EV71 vaccine) coadministered with trivalent split-virion inactivated influenza vaccine (IIV3) in infants. Methods This trial was a phase 4, randomized, controlled trial. Infants aged 6-11 months were eligible, with no history of hand, foot and mouth disease (HFMD) and no history of EV71 vaccine or any influenza vaccine. Eligible infants were randomly assigned to EV71+IIV3 group, EV71 group or IIV3 group. Blood samples were collected on day 0 and 56. Results Between September 2019 and June 2020, 1151 infants met eligibility criteria and 1134 infants were enrolled. 1045 infants were included in the per-protocol population, including 347 in the EV71+IIV3 group, 343 in the EV71 group, and 355 in the IIV3 group. The seroconversion rate (98.56% vs 98.54%; seroconversion rates difference of 0.02% [95% CI: 0.70-0.98]) and GMT (419.05 vs 503.72; GMT ratio of 0.83 [95% CI 0.70 - 0.98]) of EV71 neutralizing antibodies in the EV71+IIV3 group was not inferior to those in the EV71 group. The non-inferiority results for influenza virus antibodies (A/H1N1, A/H3N2 and B) showed that the seroconversion rates and GMTs of the EV71+IIV3 group were non-inferiority to those of the IIV3 group. Systemic and local adverse event rates were similar between groups. None of serious adverse events (SAEs) were related to vaccination. Conclusions Coadministration of the EV71 vaccine with IIV3 was safe and did not interfere with immunogenicity. These findings support a viable immunization strategy for infants with the EV71 vaccine coadministered with IIV3 in China. This trial is registered with ClinicalTrials.gov, number NCT04091880.
Collapse
Affiliation(s)
- Yaping Chen
- Immunization Programme Department, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, China
| | - Yanhui Xiao
- Medical Affairs Department, China National Biotec Group Company Limited, Beijing, China
| | - Ying Ye
- Institute for Communicable Disease Control and Prevention, Henan Provincial Center for Disease Control and Prevention, Zhengzhou, Henan, China
| | - Feng Jiang
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, Guizhou, China
| | - Hanqing He
- Immunization Programme Department, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, China
| | - Linyun Luo
- Medical Affairs Department, China National Biotec Group Company Limited, Beijing, China
| | - Haiping Chen
- Medical Affairs Department, China National Biotec Group Company Limited, Beijing, China
| | - Lubin Shi
- Institute of Expanded Programme on Immunization, Henan Provincial Center for Disease Control and Prevention, Zhengzhou, Henan, China
| | - Qiuyue Mu
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, Guizhou, China
| | - Wei Chen
- Medical Affairs Department, Wuhan Institute of Biological Products Company Limited, Wuhan, Hubei, China
| | - Xue Guo
- Medical Affairs Department, Changchun Institute of Biological Products Company Limited, Changchun, Jilin, China
| | - Min Zhang
- Medical Affairs Department, China National Biotec Group Company Limited, Beijing, China
| | - Jun Li
- Institute of Expanded Programme on Immunization, Henan Provincial Center for Disease Control and Prevention, Zhengzhou, Henan, China
| | - Qinghu Guan
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, Guizhou, China
| | - Zhiping Chen
- Immunization Programme Department, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, China,*Correspondence: Xiaoming Yang, ; Zhiping Chen,
| | - Xiaoming Yang
- Medical Affairs Department, China National Biotec Group Company Limited, Beijing, China,Research and Development Department, National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Company Limited, Wuhan, Hubei, China,*Correspondence: Xiaoming Yang, ; Zhiping Chen,
| |
Collapse
|
6
|
Zhang Y, Chen H, Lv J, Huang T, Zhang R, Zhang D, Luo L, Wei S, Liu X, Zhang S, Mu Q, Huang R, Huang J, Xiao Y, Yang Y, Han Y, Gong H, Guan Q, Xie F, Wang H, Li L, Yang X. Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes Mellitus. Vaccines (Basel) 2022; 10:vaccines10071020. [PMID: 35891184 PMCID: PMC9315836 DOI: 10.3390/vaccines10071020] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2022] [Revised: 06/14/2022] [Accepted: 06/20/2022] [Indexed: 11/25/2022] Open
Abstract
Background: To evaluate the immunogenicity and safety of the COVID-19 vaccine (Vero cell), inactivated, in a population aged ≥60 years with hypertension or(/and) diabetes mellitus. Methods: A total of 1440 participants were enrolled and divided into four groups, 330 in the hypertension group, 330 in the diabetes group, 300 in the hypertensive combined with diabetes group (combined disease group), and 480 in the healthy population group. Two doses of the COVID-19 vaccine (Vero cell), inactivated, were administered at a 21-day interval and blood samples were collected before vaccination and 28 days after the second dose to evaluate the immunogenicity. The adverse events and changes in blood pressure and blood glucose levels after vaccination were recorded. Results: The seroconversion rate of the COVID-19 neutralizing antibodies was 100% for all participants. The post-inoculation geometric mean titer (GMT) in the four groups of the hypertension, diabetes, combined disease, and healthy populations were 73.41, 69.93, 73.84, and 74.86, respectively. The seroconversion rates and post-vaccination GMT in the hypertension, diabetes, and combined disease groups were non-inferior to the healthy population group. The rates of vaccine-related adverse reactions were 11.93%, 14.29%, 12.50%, and 9.38%, respectively. No serious adverse events were reported during the study. No apparent abnormal fluctuations in blood pressure and blood glucose values were observed after vaccination in participants with hypertension or(/and) diabetes. Conclusions: The COVID-19 vaccine (Vero cell), inactivated, showed good immunogenicity and safety in patients aged ≥60 years suffering from hypertension or(/and) diabetes mellitus.
Collapse
Affiliation(s)
- Yuntao Zhang
- China National Biotech Group Co., Ltd., Beijing 100024, China; (Y.Z.); (H.C.); (L.L.); (X.L.); (Y.X.); (Y.Y.)
| | - Haiping Chen
- China National Biotech Group Co., Ltd., Beijing 100024, China; (Y.Z.); (H.C.); (L.L.); (X.L.); (Y.X.); (Y.Y.)
| | - Jun Lv
- Peking University Center for Public Health and Epidemic Preparedness & Response, Department of Epidemiology & Biostatistics, School of Public Health, Peking University, No. 38 Xueyuan Road, Haidian District, Beijing 100191, China; (J.L.); (Y.H.)
- Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - Tao Huang
- Hunan Provincial Center for Disease Control and Prevention, Changsha 410005, China; (T.H.); (S.Z.)
| | - Ruizhi Zhang
- Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, China; (R.Z.); (Q.M.); (Q.G.)
| | - Dongjuan Zhang
- Fujian Provincial Center for Disease Control and Prevention, Fuzhou 350012, China; (D.Z.); (R.H.); (F.X.)
| | - Linyun Luo
- China National Biotech Group Co., Ltd., Beijing 100024, China; (Y.Z.); (H.C.); (L.L.); (X.L.); (Y.X.); (Y.Y.)
| | - Sheng Wei
- School of Public Health, Tongji Medical School, Huazhong University of Science and Technology, Wuhan 430074, China;
| | - Xiaoqin Liu
- China National Biotech Group Co., Ltd., Beijing 100024, China; (Y.Z.); (H.C.); (L.L.); (X.L.); (Y.X.); (Y.Y.)
| | - Shangxiao Zhang
- Hunan Provincial Center for Disease Control and Prevention, Changsha 410005, China; (T.H.); (S.Z.)
| | - Qiuyue Mu
- Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, China; (R.Z.); (Q.M.); (Q.G.)
| | - Rongdong Huang
- Fujian Provincial Center for Disease Control and Prevention, Fuzhou 350012, China; (D.Z.); (R.H.); (F.X.)
| | - Jiao Huang
- Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China;
| | - Yanhui Xiao
- China National Biotech Group Co., Ltd., Beijing 100024, China; (Y.Z.); (H.C.); (L.L.); (X.L.); (Y.X.); (Y.Y.)
| | - Yunkai Yang
- China National Biotech Group Co., Ltd., Beijing 100024, China; (Y.Z.); (H.C.); (L.L.); (X.L.); (Y.X.); (Y.Y.)
| | - Yuting Han
- Peking University Center for Public Health and Epidemic Preparedness & Response, Department of Epidemiology & Biostatistics, School of Public Health, Peking University, No. 38 Xueyuan Road, Haidian District, Beijing 100191, China; (J.L.); (Y.H.)
- Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - Hao Gong
- Linli County Center for Disease Control and Prevention, Changde 415200, China;
| | - Qinghu Guan
- Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, China; (R.Z.); (Q.M.); (Q.G.)
| | - Fangqin Xie
- Fujian Provincial Center for Disease Control and Prevention, Fuzhou 350012, China; (D.Z.); (R.H.); (F.X.)
| | - Hui Wang
- Beijing Institute of Biological Products Co., Ltd., Beijing 100176, China;
| | - Liming Li
- Peking University Center for Public Health and Epidemic Preparedness & Response, Department of Epidemiology & Biostatistics, School of Public Health, Peking University, No. 38 Xueyuan Road, Haidian District, Beijing 100191, China; (J.L.); (Y.H.)
- Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing 100191, China
- Correspondence: (L.L.); (X.Y.); Tel.: +86(10)-82801528 (L.L.); +86(10)-84663009 (X.Y.); Fax: +86(10)-82801528 (L.L.); +86(10)-84663009 (X.Y.)
| | - Xiaoming Yang
- China National Biotech Group Co., Ltd., Beijing 100024, China; (Y.Z.); (H.C.); (L.L.); (X.L.); (Y.X.); (Y.Y.)
- Correspondence: (L.L.); (X.Y.); Tel.: +86(10)-82801528 (L.L.); +86(10)-84663009 (X.Y.); Fax: +86(10)-82801528 (L.L.); +86(10)-84663009 (X.Y.)
| |
Collapse
|
7
|
Zhang Y, Tian Z, Ye S, Mu Q, Wang X, Ren S, Hou X, Yu W, Guo J. Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis. Osteoporos Int 2022; 33:27-37. [PMID: 34383099 DOI: 10.1007/s00198-021-06070-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/03/2021] [Accepted: 07/12/2021] [Indexed: 10/20/2022]
Abstract
Data evaluating changes in bone mineral density (BMD) in Down syndrome (DS) individuals remains controversial. Therefore, we conducted a systematic review and meta-analysis to better understand associations between BMD and DS. A systematic literature search of PubMed, EMBASE, Web of Science, and the Cochrane Library up until 1st January 2021 was conducted. We used the keywords "bone mineral density" and "Down Syndrome." Fifteen studies were included. Overall, our results showed a significant decrease in BMD of total body (TB BMD) [MD = - 0.18; 95% CI (- 0.23 and - 0.12), P < 0.00001, I2 = 89%], total hip (TH BMD) [MD = - 0.12; 95% CI (- 0.15 and - 0.10), P < 0.00001, I2 = 0%], lumbar spine (LS BMD) [MD = - 0.12; 95% CI (- 0.14 and - 0.09), P < 0.00001, I2 = 18%], and femoral neck (FN BMD) [MD = - 0.08; 95% CI (- 0.10 and - 0.06), P < 0.00001, I2 = 0%] in DS individuals when compared with controls. Moreover, the volumetric BMD of lumbar spine (LS vBMD) [MD = - 0.01; 95% CI (- 0.02 and - 0.01), P = 0.0004, I2 = 19%] also showed a decreasing tendency while the volumetric BMD of the femoral neck (FN vBMD) [MD = 0.01; 95% CI (0.00 and 0.02), P = 0.02, I2 = 0%] was elevated in DS individuals versus controls. These findings demonstrated that individuals with DS had a decreased total and regional (TH, LS, and FN) BMD when compared with the general population. Additionally, when BMD was adjusted for skeletal volume, LS vBMD was also lower, while FN vBMD was elevated in DS individuals versus controls.
Collapse
Affiliation(s)
- Y Zhang
- Department of Pediatric, Peking University People's Hospital, Beijing, 100044, China
| | - Z Tian
- Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, 100044, China
| | - S Ye
- Department of Pediatric, Peking University People's Hospital, Beijing, 100044, China
| | - Q Mu
- Department of Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, Beijing, 100044, China
| | - X Wang
- Department of Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, Beijing, 100044, China
| | - S Ren
- Department of Pediatric, Peking University People's Hospital, Beijing, 100044, China
| | - X Hou
- Department of Pediatric, Peking University People's Hospital, Beijing, 100044, China
| | - W Yu
- Department of Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, Beijing, 100044, China.
| | - J Guo
- Department of Pediatric, Peking University People's Hospital, Beijing, 100044, China.
| |
Collapse
|
8
|
Jiang F, Zhang R, Guan Q, Mu Q, He P, Ye X, Wang W, Quan J, Li J, Liang L, Zeng F, Tang N, Xu F, Wu P, Pan Y, Yu X, Yu X, Zheng L, Zhao Y, Cai M, Li C, Zhong Y, Cao X, Yu Y, Zhang X, Zhang T, Wang P, Lei S. Immunogenicity and safety of a live attenuated varicella vaccine in children 1-12 years of age: A randomized, blinded, controlled, non-inferiority phase 3 clinical trial. Contemp Clin Trials 2021; 107:106489. [PMID: 34157417 DOI: 10.1016/j.cct.2021.106489] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 06/15/2021] [Accepted: 06/17/2021] [Indexed: 10/21/2022]
Abstract
OBJECTIVES To evaluate the immunogenicity and safety of a live attenuated varicella vaccine produced using a cell factory process. METHODS In this randomized, blinded, controlled, non-inferiority phase 3 clinical trial conducted in Guizhou, healthy children aged 1-12 years were randomly assigned in a 2: 1 ratio to receive one dose of experimental or control vaccine. Physical examination and first blood collection were performed preimmunization on day 0. Diary cards were collected after day 15. Contact cards and second blood samples were collected on day 30. The primary immunogenicity endpoint was the positive conversion rate of the anti-varicella virus antibody at 30 days postimmunization in susceptible children. Secondary endpoints were the fourfold increase rate, positive conversion rate, geometric mean titer, and geometric mean increase at 30 days after immunization in the total cohort. RESULTS Of the 900 children assessed for eligibility, 894 received an experimental or control vaccine. Both the full analysis and safety analysis sets included 894 subjects. The seroconversion rate in the susceptible population was 95.84% in the experimental and 94.76% in the control group. The lower limit of the 95% confidence interval difference was -2.37%, which was greater than the non-inferiority margin set by the program (-10%). No significant difference in solicited adverse reactions was found between the groups. Within 6 months postimmunization, a total of 24 serious adverse events were reported, none related to the studied vaccine. CONCLUSION The live attenuated varicella vaccine produced using a cell factory process was highly immunogenic, safe, and non-inferior to the product in the market. Further studies need to be implemented in the immune persistence, the epidemiological effectiveness and the rare adverse reactions.
Collapse
Affiliation(s)
- Feng Jiang
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China.
| | - Ruizhi Zhang
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Qinghu Guan
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Qiuyue Mu
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Ping He
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Xingui Ye
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Wenjian Wang
- Dejiang County Center for Disease Control and Prevention, Dejiang 520626, Guizhou Province, People's Republic of China
| | - Jidong Quan
- Dejiang County Center for Disease Control and Prevention, Dejiang 520626, Guizhou Province, People's Republic of China
| | - Jiaqiang Li
- Dejiang County Center for Disease Control and Prevention, Dejiang 520626, Guizhou Province, People's Republic of China
| | - Luxiang Liang
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Fengxiu Zeng
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Ning Tang
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Fei Xu
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Ping Wu
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Yangyang Pan
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Xiaoya Yu
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Xiaoqing Yu
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Longchao Zheng
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China
| | - Yun Zhao
- Shanghai Rongsheng Biotech Co., Ltd., Shanghai, People's Republic of China
| | - Mingyong Cai
- Shanghai Rongsheng Biotech Co., Ltd., Shanghai, People's Republic of China
| | - Cheng Li
- West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China
| | - Yang Zhong
- West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China
| | - Xiaohai Cao
- Dejiang County Center for Disease Control and Prevention, Dejiang 520626, Guizhou Province, People's Republic of China
| | - Yu Yu
- Dejiang County Center for Disease Control and Prevention, Dejiang 520626, Guizhou Province, People's Republic of China
| | - Xingyu Zhang
- Department of Systems, Populations and Leadership, University of Michigan School of Nursing, USA; Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
| | - Tao Zhang
- West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
| | - Peiyong Wang
- Shanghai Rongsheng Biotech Co., Ltd., Shanghai, People's Republic of China.
| | - Shiguang Lei
- Institute of Expanded Programme on Immunization, Guizhou Provincial Center for Disease Control and Prevention, Guiyang 550004, Guizhou Province, People's Republic of China.
| |
Collapse
|
9
|
Zuo S, Zhang D, Mu Q, Dai L, Du W, Xu F, Feng J, Heffelfinger JD. Increasing vaccination coverage: The school entry vaccination record check program in Guizhou Province China, 2003–2018. Vaccine 2020; 38:7379-7383. [DOI: 10.1016/j.vaccine.2020.08.055] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2018] [Revised: 08/04/2020] [Accepted: 08/19/2020] [Indexed: 10/23/2022]
|
10
|
Chen W, Zhao Z, Wang C, Li H, Wei R, Zhang S, Peng Z, Liu Y, Wang Q, Mu Q, Xuan L. Linear polarization grating combining a circular polarization grating with a special cycloidal diffractive quarter waveplate. Opt Express 2019; 27:33378-33390. [PMID: 31878408 DOI: 10.1364/oe.27.033378] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/11/2019] [Accepted: 10/14/2019] [Indexed: 06/10/2023]
Abstract
We introduce and demonstrate a switchable novel linear polarization grating (LPG) consisting of a circular polarization grating (CPG) and a special cycloidal diffractive quarter waveplate (CQWP). The CQWP is developed that marvelously matches the polarization-state of beams passing through the CPG. Such an LPG is so polarization-sensitive that it can split an incident linear polarized beam into two proportionally controllable left- or right-handed circularly polarized lights. We establish rigorous simulation model based on finite element method to investigate near-field polarization-state distribution of CPGs. Furthermore, LPGs are demonstrated and the diffraction properties are obtained with simulation and Jones Matrix analysis. The combination of CPGs and CQWPs is achieved with polymerizable liquid crystal. The experimental results of deflection angle and polarization selectivity of LPGs are consistent with those of simulation.
Collapse
|
11
|
Wang C, Peng Z, Liu Y, Li S, Zhao Z, Chen W, Wang Q, Mu Q. Two-dimensional symmetrical radial sub-aperture coherence and the local precision defect elimination method for high-precision beam steering. Opt Express 2019; 27:18751-18765. [PMID: 31252812 DOI: 10.1364/oe.27.018751] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/11/2019] [Accepted: 05/29/2019] [Indexed: 06/09/2023]
Abstract
Sub-aperture coherence (SAC) is a classical phase control method for high-precision beam steering using liquid crystal optical phased arrays (LCOPA). On this basis, radial sub-aperture coherence (RSAC) and symmetrical radial sub-aperture coherence (SRSAC) were proposed, which guarantee the stability of steering angles when the beam aperture and incident position fluctuate. In this article, the pre-existing one-dimensional SRSAC was firstly extended to a more universal 2D phase generation algorithm. Meanwhile, for the intractable problem of local precision defects caused by the basic two-dimensional variable period grating (2D-VPG) algorithm, we tracked their locations accurately and designed a targeted elimination method carefully. So these remarkable error peaks could be thoroughly removed by using 2D-SRSAC optimized by the local precision defect elimination method. Since then, all the excellent performance of 1D-SRSAC can be perfectly transplanted to 2D, which makes the non-mechanical beam steering technology using LCOPA more mature and competitive in the applications required ultra-high precision.
Collapse
|
12
|
Wang C, Peng Z, Liu Y, Li S, Zhao Z, Chen W, Wang Q, Mu Q. Radial sub-aperture coherence method used to achieve beam steering with high precision and stability. Opt Express 2019; 27:6331-6347. [PMID: 30876220 DOI: 10.1364/oe.27.006331] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/15/2018] [Accepted: 02/11/2019] [Indexed: 06/09/2023]
Abstract
Sub-aperture coherence (SAC) algorithm, which is based on the classical phase modulation method called variable period grating (VPG), was usually used to control liquid crystal optical phased arrays (LCOPA) to achieve agile beam steering with high precision. However, the beam steering angle of SAC is severely affected by the beam aperture, which limits the generality of the algorithm distinctly. In this article, two kinds of new phase modulation method have been proposed to solve this problem, which were named as radial sub-aperture coherence (RSAC) and symmetrical radial sub-aperture coherence (SRSAC). By using RSAC, the holistic drift of steering angle, which is caused by the variation of beam aperture, can be effectively avoided. In addition, a series of equidistant steering points with ultra-high precision can be obtained. Upon this basis, SRSAC greatly enhances the steering angle's stability in the presence of system alignment error and relative vibration. Thus, the practicability of LCOPA for beam steering can be improved effectively.
Collapse
|
13
|
Wang Y, Chen X, Cao Z, Zhang X, Liu C, Mu Q. Gradient cross-correlation algorithm for scene-based Shack-Hartmann wavefront sensing. Opt Express 2018; 26:17549-17562. [PMID: 30119566 DOI: 10.1364/oe.26.017549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/23/2018] [Accepted: 06/04/2018] [Indexed: 06/08/2023]
Abstract
Scene-based wavefront sensing currently uses the periodic-correlation algorithm based on fast Fourier transforms. However, when the object scene contains features at the field edges, the performance of the algorithm is poor due to the periodicity of fast Fourier transforms, called wraparound effect. In this paper, we propose an algorithm based on the gradient cross-correlation. Both simulation and experiment results show its dramatic effectiveness against the wraparound effect, and a considerable improvement is obtained in image resolution with closed loop adaptive optics correction.
Collapse
|
14
|
Teng S, Guo Z, Peng H, Xing G, Chen H, He B, McClure M, Mu Q. High-frequency repetitive transcranial magnetic stimulation over the left DLPFC for major depression: Session-dependent efficacy: A meta-analysis. Eur Psychiatry 2017; 41:75-84. [DOI: 10.1016/j.eurpsy.2016.11.002] [Citation(s) in RCA: 64] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/13/2016] [Revised: 11/02/2016] [Accepted: 11/02/2016] [Indexed: 01/18/2023] Open
Abstract
AbstractBackgroundDepression is a major debilitating psychiatric disorder. Current antidepressant drugs are often associated with side effects or treatment resistance. The aim of this meta-analysis was to evaluate therapeutic effects of high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) in major depression (MD).MethodsThe medical data bases of PubMed, Medline, Embase and Cochrane Central Register were searched for randomized controlled trials (RCTs) reporting the therapeutic effects of high-frequency rTMS for depression, which were published in English between January 1990 and June 2016. The index terms were “depress*”, “depression” and “transcranial magnetic stimulation”. Depression outcome data of different sessions (5, 10, 15, and 20 sessions of rTMS treatment) were extracted and synthesized by calculating standardized mean difference (SMD) with 95% confidence intervals (CI) by using a random-effect model. Within each session group, the subgroup analyses based on the number of pulses (≤ 1000, 1200–1500, 1600–1800, and 2000–3000) were also conducted.ResultsThirty RCTs with a total of 1754 subjects including 1136 in the rTMS group and 618 in the sham group were included in this meta-analysis. rTMS had a significant overall therapeutic effect on depression severity scores (SMD = −0.73, P < 0.00001). The five, 10, 15, 20 sessions of rTMS treatments yielded the significant mean effect sizes of −0.43, −0.60, −1.13, and −2.74, respectively. In the four groups (5, 10, 15, 20 sessions), the maximal mean effect size was all obtained in the subgroup of 1200–1500 pulses per day (−0.97, −1.14, −1.91, −5.47; P < 0.05).ConclusionsThe increasing of HF-rTMS sessions is associated with the increased efficacy of HF-rTMS in reducing depressed patients’ symptom severity. A total number of pulses of 1200–1500 per day appear to deliver the best antidepressant effects of HF-rTMS.
Collapse
|
15
|
Zeng B, Yan HD, Huang LK, Wang YC, Wu JH, Huang X, Zhang AL, Wang CR, Mu Q. Orthogonal design in the optimization of a start codon targeted (SCoT) PCR system in Roegneria kamoji Ohwi. Genet Mol Res 2016; 15:gmr-15-gmr15048968. [PMID: 27813608 DOI: 10.4238/gmr15048968] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Roegneria kamoji Ohwi is an excellent forage grass due to its high feeding value and high resistance to some biotic and abiotic stresses. However, the start codon targeted (SCoT) polymorphism has not been conducted on R. kamoji. In this study, an orthogonal L16 (45) design was employed to investigate the effects of five factors (Mg2+, dNTPs, Taq DNA polymerase, primer, and template DNA) on the polymerase chain reaction (PCR) to determine the optimal SCoT-PCR system for R. kamoji. The results showed that the most suitable conditions for SCoT-PCR in R. kamoji included 1.5 mM Mg2+, 0.15 mM dNTPs, 1.0 U Taq DNA polymerase, 0.4 pM primer, and 40 ng template DNA. SCoT primers 39 and 41 were used to verify the stability of the optimal reaction system, and amplification bands obtained from diverse samples were found to be clear, rich, and stable in polymorphisms, indicating that this reaction system can be used for SCoT-PCR analysis of R. kamoji. We have developed a simple and rapid way to study the mutual effects of factors and to obtain positive results through the use of an orthogonal design L16 (45) to optimize the SCoT-PCR system. This method may provide basic information for molecular marker-assisted breeding and analyses of genetic diversity in R. kamoji.
Collapse
Affiliation(s)
- B Zeng
- Department of Animal Science, Southwest University, Rongchang, Chongqing Province, China
| | - H D Yan
- Department of Grassland Science, Animal Science and Technology College, Sichuan Agricultural University, Chengdu, Sichuan, China
| | - L K Huang
- Department of Grassland Science, Animal Science and Technology College, Sichuan Agricultural University, Chengdu, Sichuan, China
| | - Y C Wang
- Animal Husbandry and Veterinary Research Institute of Guizhou Province, Guizhou, Guiyang, China
| | - J H Wu
- Guizhou Institute of Prataculture, Guizhou, Dushan, China
| | - X Huang
- Department of Grassland Science, Animal Science and Technology College, Sichuan Agricultural University, Chengdu, Sichuan, China
| | - A L Zhang
- Department of Grassland Science, Animal Science and Technology College, Sichuan Agricultural University, Chengdu, Sichuan, China
| | - C R Wang
- Department of Grassland Science, Animal Science and Technology College, Sichuan Agricultural University, Chengdu, Sichuan, China
| | - Q Mu
- Guizhou Institute of Prataculture, Guizhou, Dushan, China
| |
Collapse
|
16
|
Rao SS, Mu Q, Zeng Y, Cai PC, Liu F, Yang J, Xia Y, Zhang Q, Song LJ, Zhou LL, Li FZ, Lin YX, Fang J, Greer PA, Shi HZ, Ma WL, Su Y, Ye H. Calpain-activated mTORC2/Akt pathway mediates airway smooth muscle remodelling in asthma. Clin Exp Allergy 2016; 47:176-189. [PMID: 27649066 DOI: 10.1111/cea.12805] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2015] [Revised: 07/20/2016] [Accepted: 08/09/2016] [Indexed: 12/11/2022]
Abstract
BACKGROUND Allergic asthma is characterized by inflammation and airway remodelling. Airway remodelling with excessive deposition of extracellular matrix (ECM) and larger smooth muscle mass are correlated with increased airway responsiveness and asthma severity. Calpain is a family of calcium-dependent endopeptidases, which plays an important role in ECM remodelling. However, the role of calpain in airway smooth muscle remodelling remains unknown. OBJECTIVE To investigate the role of calpain in asthmatic airway remodelling as well as the underlying mechanism. METHODS The mouse asthma model was made by ovalbumin sensitization and challenge. Calpain conditional knockout mice were studied in the model. Airway smooth muscle cells (ASMCs) were isolated from smooth muscle bundles in airway of rats. Cytokines IL-4, IL-5, TNF-α, and TGF-β1, and serum from patients with asthma were selected to treated ASMCs. Collagen-I synthesis, cell proliferation, and phosphorylation of Akt in ASMCs were analysed. RESULTS Inhibition of calpain using calpain knockout mice attenuated airway smooth muscle remodelling in mouse asthma models. Cytokines IL-4, IL-5, TNF-α, and TGF-β1, and serum from patients with asthma increased collagen-I synthesis, cell proliferation, and phosphorylation of Akt in ASMCs, which were blocked by the calpain inhibitor MDL28170. Moreover, MDL28170 reduced cytokine-induced increases in Rictor protein, which is the most important component of mammalian target of rapamycin complex 2 (mTORC2). Blockage of the mTORC2 signal pathway prevented cytokine-induced phosphorylation of Akt, collagen-I synthesis, and cell proliferation of ASMCs and attenuated airway smooth muscle remodelling in mouse asthma models. CONCLUSIONS AND CLINICAL RELEVANCE Our results indicate that calpain mediates cytokine-induced collagen-I synthesis and proliferation of ASMCs via the mTORC2/Akt signalling pathway, thereby regulating airway smooth muscle remodelling in asthma.
Collapse
Affiliation(s)
- S-S Rao
- Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Q Mu
- Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Y Zeng
- Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - P-C Cai
- Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - F Liu
- Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - J Yang
- Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Y Xia
- Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Q Zhang
- Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - L-J Song
- Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - L-L Zhou
- Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - F-Z Li
- Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Y-X Lin
- Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - J Fang
- Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - P A Greer
- Queen's University Cancer Research Institute, Kingston, ON, Canada
| | - H-Z Shi
- Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
| | - W-L Ma
- Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.,Key Laboratory of Pulmonary Diseases, Ministry of Health of China, Wuhan, Hubei, China
| | - Y Su
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Charlie Norwood Veterans Affairs Medical Center, Augusta, GA, USA
| | - H Ye
- Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.,Key Laboratory of Pulmonary Diseases, Ministry of Health of China, Wuhan, Hubei, China
| |
Collapse
|
17
|
Xiao S, Mu Q, Wan Y, Xue M. Spontaneous renal hemorrhage caused by invasive mole: a case report. EUR J GYNAECOL ONCOL 2016; 37:417-419. [PMID: 27352577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
CASE The authors report a case with spontaneous renal hemorrhage caused by invasive mole. The diagnosis was gestational trophoblastic disease (GTD), with metastasis to brain, kidneys, and lungs at Stage IV. The patient was given etoposide-methotrexate-actinomycin D plus cyclophosphamide-vincristine (EMACO) treatment regimen for 11 times including three times with consolidation chemotherapies. Laparoscopically-assisted vaginal hysterectomy (LAVH) + laparoscopic-assisted left renal excision + evacuation of the left perirenal hematoma were performed during the eighth chemotherapy. CONCLUSION Post-operational pathological examination revealed trophoblasts within the lesions present in uterine fundus and the residue images of a few trophoblasts present in the left renal mass.
Collapse
|
18
|
Sun X, Mu Q, Jiang D, Wang C, Wang XC, Fang JG. A new strategy employed for identification of sweet orange cultivars with RAPD markers. Genet Mol Res 2012; 11:2071-80. [PMID: 22911591 DOI: 10.4238/2012.august.6.11] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
We optimized RAPD techniques by increasing the length of RAPD primers and performing a strict screening of PCR annealing temperature to distinguish 60 sweet orange cultivars from the Research Institute of Pomology at the Chinese Academy of Agricultural Sciences. A new approach called cultivar identification diagram (CID) was used to improve the efficiency of RAPD markers for cultivar identification. Thirteen effective primers were first screened from 54 RAPD arbitrary 11-mer primers based on their amplification products and amplified polymorphic bands; they were then used for PCR amplification of all 60 cultivars. All cultivars were manually and completely separated by the polymorphic bands appearing in DNA fingerprints from 13 primers; a CID of the 60 sweet orange cultivars was then constructed. This CID separated all the cultivars from each other, based on the polymorphic bands; the corresponding primers were marked in the correct positions on the sweet orange CID. The CID strategy facilitates the identification of fruit cultivars with DNA markers. This CID of sweet orange cultivars will be very useful for the protection of cultivar rights and for early identification of seedlings in the nursery industry.
Collapse
Affiliation(s)
- X Sun
- College of Horticulture, Nanjing Agricultural University, Nanjing, P.R. China
| | | | | | | | | | | |
Collapse
|
19
|
Zhang Y, Mu Q, Zhou H, Vrijens K, Roussel MF, Jiang G, Yan B. Binding of carbon nanotube to BMP receptor 2 enhances cell differentiation and inhibits apoptosis via regulating bHLH transcription factors. Cell Death Dis 2012; 3:e308. [PMID: 22573038 PMCID: PMC3366082 DOI: 10.1038/cddis.2012.48] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Biomaterials that can drive stem cells to an appropriate differentiation level and decrease apoptosis of transplanted cells are needed in regenerative medicine. Nanomaterials are promising novel materials for such applications. Here we reported that carboxylated multiwalled carbon nanotube (MWCNT 1) promotes myogenic differentiation of mouse myoblast cells and inhibits cell apoptosis under the differentiation conditions by regulating basic helix-loop-helix transcription factors. MWCNT 1 attenuates bone morphogenetic protein receptor (BMPR) signaling activity by binding to BMPR2 and attenuating the phosphorylation of BMPR1. This molecular understanding allowed us to tune stem cell differentiation to various levels by chemical modifications, demonstrating human control of biological activities of nanoparticles and opening an avenue for potential applications of nanomaterials in regenerative medicine.
Collapse
Affiliation(s)
- Y Zhang
- School of Pharmaceutical Sciences, Shandong University, Jinan 250100, China
| | | | | | | | | | | | | |
Collapse
|
20
|
Shengbo Y, Qingyan Z, He H, Donge C, Mu Q, Congxin H. e0249 Prognostic value of premature ventricular contraction originating from different location for patients with chronic heart failure. Heart 2010. [DOI: 10.1136/hrt.2010.208967.249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
21
|
Chang H, Xu J, Mu Q, Qin C, Zhang Z, Wu T. Occult hepatocellular carcinoma: a case report of a special icteric-type hepatoma and literature review. Eur J Cancer Care (Engl) 2009; 19:690-3. [PMID: 19659667 DOI: 10.1111/j.1365-2354.2008.01035.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Hepatocellular carcinoma (HCC) presenting with obstructive jaundice due to bile duct tumour thrombi is classified as icteric-type hepatoma. This report describes a case of unusual icteric-type HCC with common bile duct thrombus, which is herein named 'occult HCC', as no detectable primary lesion in liver was defined pre-operatively and intra-operatively. A thrombectomy followed by a T biliary drainage tube placement was carried out, and the final post-operative pathological evaluation demonstrated the tumour thrombus originated from a moderately differentiated HCC. The clinicopathological features and logical clinical interventions of this rare type of HCC were discussed with a review of the literature. The HCC patients with bile duct thrombi receiving palliative biliary drainage alone had a poor outcome. With respect to improving prognosis, a curative resection of primary HCC and tumour thrombi was suggested on the basis of performing an intensive post-operative monitoring for early detection of primary liver lesion.
Collapse
Affiliation(s)
- H Chang
- Department of Hepatobiliary & Pancreatic Surgery, Shandong Provincial Hospital, Shandong University School of Medicine, Shandong, China.
| | | | | | | | | | | |
Collapse
|
22
|
Hu L, Xuan L, Li D, Cao Z, Mu Q, Liu Y, Peng Z, Lu X. Wavefront correction based on a reflective liquid crystal wavefront sensor. ACTA ACUST UNITED AC 2008. [DOI: 10.1088/1464-4258/11/1/015511] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
23
|
Mu Q, Teng RW, Li CM, Wang DZ, Wu Y, Sun HD, Hu CQ. Leiocyclocin C and D, two cyclopeptides from Goniothalamus leiocarpus. Pharmazie 2003; 58:756-8. [PMID: 14609292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
Two new cyclopeptides, leiocyclocin C (1) and D (2), were isolated from the seeds of Goniothalamus leiocarpus (Annonaceae). Their structures were determined as cyclo-(Gly1-Ser-Pro2-Tyr2-Gly2-Tyr1-Pro1-Pro3) and cyclo-(Gly1-Leu-Pro1-Gly2-Phe-Tyr-Pro2), respectively, by means of spectral and chemical methods.
Collapse
Affiliation(s)
- Q Mu
- School of Pharmacy, Fudan University, Shanghai, China.
| | | | | | | | | | | | | |
Collapse
|
24
|
Wen Z, Xie J, Guan Z, Sun D, Yao W, Chen K, Yan ZY, Mu Q. A study of hemorheological behaviour for patients with Alzheimer's disease at the early stages. Clin Hemorheol Microcirc 2001; 22:261-6. [PMID: 11081463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
To evaluate the change of hemorheological indexes for patients with Alzheimer's disease (AD) at the early stages and to discuss effects of these changes on AD, high shear value of whole blood viscosity (etabh), reduced high shear value of whole blood viscosity (retabh), low shear value of whole blood viscosity (etabl), reduced low shear, value of whole blood viscosity (retabl), KT value of whole blood viscosity, hematocrit (HCT) and blood plasma viscosity (etaP) were measured in 31 patients with probable AD at the early stages and 33 age-matched healthy subjects. There were significant differences of all hemorheological indexes between AD group and control group except HCT. Step discriminant analysis revealed 81.25% of overall group-classified accuracy in a hemorheological discriminant function consisting of etabl, retabl, retabh and HCT. Significant difference of hemorheological indexes existed between AD and age-matched healthy control subjects. The results showed that measurement of hemorheological indexes could be used as one of reference standards of diagnosis in AD.
Collapse
Affiliation(s)
- Z Wen
- Department of Medical Physics, Beijing Medical University, PR China.
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Emanuel RL, Torday JS, Mu Q, Asokananthan N, Sikorski KA, Sunday ME. Bombesin-like peptides and receptors in normal fetal baboon lung: roles in lung growth and maturation. Am J Physiol 1999; 277:L1003-17. [PMID: 10564187 DOI: 10.1152/ajplung.1999.277.5.l1003] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Previously, we have shown that bombesin-like peptide (BLP) promotes fetal lung development in rodents and humans but mediates postnatal lung injury in hyperoxic baboons. The present study analyzed the normal ontogeny of BLP and BLP receptors as well as the effects of BLP on cultured normal fetal baboon lungs. Transcripts encoding gastrin-releasing peptide (GRP), a pulmonary BLP, were detectable on gestational day 60 (ED60), peaked on approximately ED90, and then declined before term (ED180). Numbers of BLP-immunopositive neuroendocrine cells peaked from ED80 to ED125 and declined by ED160, preceding GRP-receptor mRNAs detected from ED125 until birth. BLP (0.1-10 nM) stimulated type II cell differentiation in organ cultures as assessed by [(3)H]choline incorporation into surfactant phospholipids, electron microscopy, and increased surfactant protein (SP) A- and/or SP-C-immunopositive cells and SP-A mRNA. BLP also induced neuroendocrine differentiation on ED60. Cell proliferation was induced by GRP, peaking on ED90. Similarly, blocking BLP degradation stimulated lung growth and maturation, which was completely reversed by a BLP-specific antagonist. The dissociation between GRP and GRP-receptor gene expression during ontogeny suggests that novel BLP receptors and/or peptides might be implicated in these responses.
Collapse
Affiliation(s)
- R L Emanuel
- Department of Medicine, Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
| | | | | | | | | | | |
Collapse
|
26
|
Sunday ME, Haley KJ, Sikorski K, Graham SA, Emanuel RL, Zhang F, Mu Q, Shahsafaei A, Hatzis D. Calcitonin driven v-Ha-ras induces multilineage pulmonary epithelial hyperplasias and neoplasms. Oncogene 1999; 18:4336-47. [PMID: 10439041 DOI: 10.1038/sj.onc.1202810] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
We initiated a transgenic model for primary pulmonary neuroendocrine cell (PNEC) hyperplasia/neoplasia using v-Ha-ras driven by the neural/neuroendocrine (NE)-specific calcitonin promoter (rascal). Previously, we showed that nitrosamine treated rodents develop PNEC hyperplasia but non-NE lung tumors, with variable outcomes presumably reflecting ras activation in multiple cell lineages. Interestingly, all rascal transgenic mouse lineages develop hyperplasias of NE and non-NE cells but mostly non-NE lung carcinomas, with rascal mRNA in differentiated PNECs and tumor cells. Analyses of embryonic lung demonstrate rascal mRNA in undifferentiated epithelium, consistent with expression in a common pluripotent precursor cell. These unexpected observations indicate that v-Ha-ras can lead to both NE and non-NE hyperplasia/neoplasia in vivo, opening new avenues for studies of lung carcinogenesis.
Collapse
Affiliation(s)
- M E Sunday
- Children's Hospital, Brigham and Women's Hospital, Boston, Massachusetts, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Mu Q, Xie J, Wen Z, Weng Y, Shuyun Z. A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age. AJNR Am J Neuroradiol 1999; 20:207-11. [PMID: 10094339 PMCID: PMC7056110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
Abstract
BACKGROUND AND PURPOSE Several investigators have defined normal age-specific values for the medial temporal lobe structures in neurologically normal elderly subjects, but, to our knowledge, no one has reported those values for a large sample of healthy volunteers. The purpose of our study was to define normal age-specific values for the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle by age group, ranging from 40 to 90 years, in order to generate a guideline for the quantitative MR diagnosis and differential diagnosis for early Alzheimer disease. METHODS MR-based volumetric measurements of the hippocampal formation, the amygdala, and the temporal horn, standardized by total intracranial volume, were obtained from oblique coronal and sagittal T1-weighted MR images in 619 healthy volunteers and two cadaveric specimens. RESULTS Differences in standardized volumes of the hippocampal formation, the amygdala, and the temporal horn were significant among the 61- to 70-year-old, 71- to 80-year-old, and 81- to 90-year-old groups, and were not significant between the 40- to 50-year-old and 51- to 60-year-old groups. We found no significant differences in side or sex among the age groups for any of the structures. CONCLUSION Differences in the mean value and in the 95% normal range of standardized volumes of the hippocampal formation, the amygdala, and the temporal horn correspond to differences in age among healthy subjects; therefore, age should be considered a factor in correlative research, especially in that involving patients in the early stages of Alzheimer disease.
Collapse
Affiliation(s)
- Q Mu
- Department of Radiology, the Third School of Clinical Medicine, Beijing Medical University, China
| | | | | | | | | |
Collapse
|
28
|
Mu Q, Li C, Sun H. [Chemical constituents of Coleus carnosifolius Dunn]. Zhongguo Zhong Yao Za Zhi 1996; 21:104-5, 128. [PMID: 8758764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Four compounds were isolated from Coleus carnosifolius. They were identified as betulic acid, betulin, oleanic acid and beta-sitosterol by spectral analysis and comparison with authentic samples.
Collapse
Affiliation(s)
- Q Mu
- Laboratory of Phytochemistry, Kunming Institute of Botany, Academia Sinica
| | | | | |
Collapse
|